查詢結果分析
來源資料
相關文獻
- HER2陽性轉移性乳癌之標靶藥物回顧
- Durable Response to Lapatinib Plus Capecitabine in Trastuzumab--Resistant HER2 Over-expressing Metastatic Breast Cancer
- 賀癌平(Herceptin)/化學治療在轉移性乳癌之角色
- Treatment Outcome in Women with Operable HER2-positive Breast Cancer: A Single Institutional Report
- Cardiotoxicity Associated with Trastuzumab Therapy in Taiwan: A Single Medical Center's 5-Year Experience
- Fever, Rash and Acute Inflammatory Polyarthritis in a Breast Cancer Patient after Trastuzumab Treatment: a Case Report
- Neoadjuvant Trastuzumab Concurrent with Nonanthracycline-based Regimens for HER2-positive Locally Advanced Breast Cancer
- HER2陽性轉移性乳癌治療新希望--從護理的觀點談賀癌寧(Trastuzumab Emtansine)及其照護
- Trastuzumab for HER-2-Positive Advanced Salivary Gland Cancer
- 細胞表皮生長因子受體與乳癌標靶治療
頁籤選單縮合
題名 | HER2陽性轉移性乳癌之標靶藥物回顧=Review of Targeted Therapy for HER2-Positive Metastatic Breast Cancer |
---|---|
作者 | 陳佩瑛; 陳怡君; | 書刊名 | 臺灣醫學 |
卷期 | 19:5 2015.09[民104.09] |
頁次 | 頁528-533 |
分類號 | 416.226、416.226 |
關鍵詞 | HER2陽性; 賀癌平; 泰嘉錠; 賀疾妥; 賀癌寧; HER2-positive; Trastuzumab; Lapatinib; Pertuzumab; Ado-trantuzumab emtansine; |
語文 | 中文(Chinese) |